These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6111645

  • 1. Survival of hepatitis B virus after drying and storage for one week.
    Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE.
    Lancet; 1981 Mar 07; 1(8219):550-1. PubMed ID: 6111645
    [No Abstract] [Full Text] [Related]

  • 2. Illness in a chimpanzee inoculated with hepatitis B virus.
    Sly DL, London WT, Purcell RH.
    J Am Vet Med Assoc; 1979 Nov 01; 175(9):987-8. PubMed ID: 521389
    [No Abstract] [Full Text] [Related]

  • 3. The clinical significance of the delta antigen-antibody system in hepatitis B infections.
    Rizzetto M, Smedile A, Farci P.
    Scand J Infect Dis Suppl; 1982 Nov 01; 36():74-5. PubMed ID: 6963757
    [No Abstract] [Full Text] [Related]

  • 4. [What should a vaccine against hepatitis B be like?].
    Anan'ev VA, Zhdanov VM.
    Vopr Virusol; 1978 Nov 01; (6):643-9. PubMed ID: 86238
    [No Abstract] [Full Text] [Related]

  • 5. Vaccine against human hepatitis B. 1976.
    Buynak EB, Roehm RR, Tytell AA, Bertland AU, Lampson GP, Hillerman MR.
    JAMA; 1996 Dec 11; 276(22):1793-5. PubMed ID: 8946889
    [No Abstract] [Full Text] [Related]

  • 6. The protection of chimpanzees against hepatitis B viral infection using a recombinant yeast-derived hepatitis B surface antigen.
    Schellekens H, de Reus A, Peetermans JH, van Eerd PA.
    Postgrad Med J; 1987 Dec 11; 63 Suppl 2():93-6. PubMed ID: 3317363
    [Abstract] [Full Text] [Related]

  • 7. [Infectivity of hepatitis B].
    Gerken G.
    Dtsch Med Wochenschr; 1996 Apr 05; 121(14):459. PubMed ID: 8665822
    [No Abstract] [Full Text] [Related]

  • 8. Attempts to transmit hepatitis B virus to chimpanzees by arthropods.
    Jupp PG, Purcell RH, Phillips JM, Shapiro M, Gerin JL.
    S Afr Med J; 1991 Mar 16; 79(6):320-2. PubMed ID: 2017742
    [Abstract] [Full Text] [Related]

  • 9. Reactivation of hepatitis B.
    Lancet; 1989 May 13; 1(8646):1083-4. PubMed ID: 2566036
    [No Abstract] [Full Text] [Related]

  • 10. [Vaccines against hepatitis B].
    Viazov SO.
    Vopr Virusol; 1984 May 13; 29(6):656-63. PubMed ID: 6396952
    [No Abstract] [Full Text] [Related]

  • 11. Prophylaxis of hepatitis type B: immunoglobulins and vaccines.
    Zuckerman AJ.
    Clin Gastroenterol; 1980 Jan 13; 9(1):65-83. PubMed ID: 6994953
    [No Abstract] [Full Text] [Related]

  • 12. Identification and transmission of hepatitis B virus-related variants.
    Wands JR, Fujita YK, Isselbacher KJ, Degott C, Schellekens H, Dazza MC, Thiers V, Tiollais P, Brechot C.
    Proc Natl Acad Sci U S A; 1986 Sep 13; 83(17):6608-12. PubMed ID: 3462716
    [Abstract] [Full Text] [Related]

  • 13. The hepatitis B virus.
    Blumberg BS.
    Public Health Rep; 1980 Sep 13; 95(5):427-35. PubMed ID: 6252570
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the morphological alteration and disintegration test (MADT) and the chimpanzee infectivity test for determination of hepatitis B virucidal activity of chemical disinfectants.
    Thraenhart O, Kuwert EK, Scheiermann N, Dermietzel R, Paar D, Maruhn D, Alberti A, Richter HJ, Hotz J.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1982 Sep 13; 176(5-6):472-84. PubMed ID: 7158127
    [Abstract] [Full Text] [Related]

  • 15. Orcein-positive hepatocytes in hepatitis B: morphologic evidence of chronic hepatitis B virus infection?
    Karasawa T, Shikata T, Abe K, Tanaka K, Ueda T, Kunugi M, Oda T.
    Arch Pathol Lab Med; 1981 Jul 13; 105(7):388. PubMed ID: 6894694
    [No Abstract] [Full Text] [Related]

  • 16. Nondetection of infectious hepatitis B virus in a human hepatoma cell line producing hepatitis B surface antigen.
    Tabor E, Copeland JA, Mann GF, Howard CR, Skelly J, Snoy P, Zuckerman AJ, Gerety RJ.
    Intervirology; 1981 Jul 13; 15(2):82-6. PubMed ID: 7298300
    [Abstract] [Full Text] [Related]

  • 17. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).
    Page M, Jones CD, Bailey C.
    Intervirology; 2001 Jul 13; 44(2-3):88-97. PubMed ID: 11509870
    [Abstract] [Full Text] [Related]

  • 18. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.
    Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M.
    Proc Natl Acad Sci U S A; 1986 Dec 13; 83(23):9174-8. PubMed ID: 3466181
    [Abstract] [Full Text] [Related]

  • 19. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.
    Ogata N, Ostberg L, Ehrlich PH, Wong DC, Miller RH, Purcell RH.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):3014-8. PubMed ID: 8464917
    [Abstract] [Full Text] [Related]

  • 20. Seroconversion from hepatitis B e antigen to anti-HBe in acute hepatitis B virus infection.
    Aikawa T, Sairenji H, Furuta S, Kiyosawa K, Shikata T, Imai M, Miyakawa Y, Yanase Y, Mayumi M.
    N Engl J Med; 1978 Feb 23; 298(8):439-41. PubMed ID: 622119
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.